<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5D690D36-8CF6-4E46-BEC3-BD110842CA1C"><gtr:id>5D690D36-8CF6-4E46-BEC3-BD110842CA1C</gtr:id><gtr:name>International League Against Epilepsy (ILAE)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>UCL Genetics Institute</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5D690D36-8CF6-4E46-BEC3-BD110842CA1C"><gtr:id>5D690D36-8CF6-4E46-BEC3-BD110842CA1C</gtr:id><gtr:name>International League Against Epilepsy (ILAE)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A0C84AAC-AC07-4E32-9B11-3E8DB0AA5F3D"><gtr:id>A0C84AAC-AC07-4E32-9B11-3E8DB0AA5F3D</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>Roy</gtr:otherNames><gtr:surname>Johnson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B502872D-53F9-42EB-8D1E-45D7522C3D98"><gtr:id>B502872D-53F9-42EB-8D1E-45D7522C3D98</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Wood</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A7101596-9388-40E0-AFDE-12DB6BAD3308"><gtr:id>A7101596-9388-40E0-AFDE-12DB6BAD3308</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Balding</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0901388"><gtr:id>1044EDF2-3F73-4C6C-A6A1-C0A1DCC5D3A4</gtr:id><gtr:title>Statistical Methods for Pharamacogenetics</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0901388</gtr:grantReference><gtr:abstractText>Pharmacogenetics is the use of genetic information to improve the prescribing of drugs, either through rapid prediction of the correct dose for a patient according to his/her genetic type, or by avoiding the prescription of drugs to those with unsuitable genetic types. Until recently pharmacogenetics was focussed on a small number of genes known to be involved in drug transport or action, but increasingly genetic data from the whole genome is taken into account. Although so-called personalised medicine has been talked about for many years now, the achievements to date in this area remain limited to a few diseases and drugs. One bottleneck in the process is efficient statistical analysis of datasets that are often relatively small, but complex in terms of both the outcome measures made on patients and the diversity of patients and their treatments. The goal of this proposal is to develop and make available better statistical methods that can help make pharmacogenetics more productive.</gtr:abstractText><gtr:technicalSummary>Pharmacogenetics (PGx) has the potential to generate improved drug therapies for patients, particularly in more accurate dose-finding and avoidance of adverse events, as well as economic benefits to the pharmaceutical industry (possibility to rescue drugs not currently marketable) and to healthcare providers such as the NHS (reduced prescriptions of ineffective or harmful drugs). Broadly speaking, PGx has until now failed to deliver substantial return on investment, but the potential rewards are so great that continuing effort and investment is warranted. Because of small and heterogeneous datasets, appropriate statistical analyses are crucial to maximising the output of pharmacogenetics research, but to date there appears to have been relatively little investment, at least in the public sector, in the development of statistical methods tailored to the needs of PGx research. In this proposal we seek to make several contributions to statistical methodology to enhance the prospects of PGx, focussing on two broad strands: (1) the prediction of drug response from genome-wide genetic data, and (2) Bayesian modelling of population and other sources of heterogeneity in order to extract more information from complex data sets.</gtr:technicalSummary><gtr:fund><gtr:end>2014-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>542591</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>International League Against Epilepsy (ILAE)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>International League Against Epilepsy (ILAE) Consortium on Complex Epilepsies</gtr:description><gtr:id>5691A247-02BF-4C24-8157-EE36226DA0E0</gtr:id><gtr:impact>So far, the ILAE has published the 2014 Lancet Neurology paper (see Publications) which reports results from the consortium's primary analysis. Three follow-up studies are nearing publication.</gtr:impact><gtr:outcomeId>544e563fb3dd53.16344670-1</gtr:outcomeId><gtr:partnerContribution>By combining data across cohorts, the ILAE is able to analyse over 50,000 samples, making it by far the largest epilepsy genetic study.</gtr:partnerContribution><gtr:piContribution>The ILAE is a multi-centre consortium, set up to combine data from epilepsy groups across four continents. We have been heavily involved in the analysis by writing the analysis protocols and performing these on behalf of the SANAD (Liverpool-based epilepsy drug trial) and Melbourne cohorts.</gtr:piContribution><gtr:sector>Learned Society</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>DataDive - community data analysis workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>199506C2-0CDA-423A-A2FA-931C517845B8</gtr:id><gtr:impact>Approximately 100 analysts (a combination of scientific researchers, charity officials, and enthusiastic volunteers) spent a weekend working over data problems identified by three local / national charities. The common theme was combining skills to analyse the charity's data, and aim to provide guidelines on future decision making; for example, what signs can be used to identify individuals likely to become homeless, and on which areas should more attention be placed.

By the end of the weekend, a web package was developed to mine data for simple trends, on which the charities could then take action.</gtr:impact><gtr:outcomeId>544d7f2d85d269.34057735</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.datakind.org/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>444000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Strategic Skills Career Development Award in Biostatistics</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L012561/1</gtr:fundingRef><gtr:id>15DA0B4C-18D9-45E9-A628-A01771605F9B</gtr:id><gtr:outcomeId>544f7e16e86d07.90118398</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>LDAK is software for investigating the aetiology and predicting complex traits. It's primary aim is to obtain kinship coefficients corrected for Linkage Disequilibrium, which can otherwise bias estimates of heritability, however, it also includes our published prediction method, MultiBLUP, as well as features for generating risk scores, and performing gene-based analyses.</gtr:description><gtr:id>7965A026-1094-4FD8-878C-21C263766328</gtr:id><gtr:impact>The website is receiving a few hundred hits per month, with over 100 registered users since the latest update (March 2014), and now beginning to be cited in other group's publications.</gtr:impact><gtr:outcomeId>Hd5MHZ4EhEe</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>LDAK</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.ldak.org</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>LDAK is an evolving software (written in C) for analysing genetic association study data. Originally, it was designed for computing SNP weights which enable more accurate estimates of heritability. Now, LDAK also contains MultiBLUP, our software for constructing linear prediction models which outperforms all existing methods that we have been able to compare with. LDAk can also compute genetic profile risk scores and perform gene-based analysis and meta-analysis.</gtr:description><gtr:id>AFDAC2EA-FE73-477C-9903-1D2D961E5CAE</gtr:id><gtr:impact>Methodological aspects of LDAK (the SNP weightings and MultiBLUP prediction) are described in the American Journal of Human Genetics and Genome Research publications attached to Grant G0300766, while LDAK was used for the Brain and Lancet Neurology papers also on the grant.</gtr:impact><gtr:outcomeId>544d8d969e65c1.15310432</gtr:outcomeId><gtr:title>LDAK</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://www.ldak.org</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>67793E9A-49EB-48BD-9F0A-2964342348E9</gtr:id><gtr:title>A genome-wide association study identifies multiple loci for variation in human ear morphology.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6337d652fbd026f37ce0cdac8e83f249"><gtr:id>6337d652fbd026f37ce0cdac8e83f249</gtr:id><gtr:otherNames>Adhikari K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58b4e223153302.10615670</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F153C7A-B4C9-4F92-882E-1CC66ED998DE</gtr:id><gtr:title>Understanding complex traits: from farmers to pharmas.</gtr:title><gtr:parentPublicationTitle>Genome medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/025466a6f52378a6cb32de7d945b59cf"><gtr:id>025466a6f52378a6cb32de7d945b59cf</gtr:id><gtr:otherNames>Speed D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1756-994X</gtr:issn><gtr:outcomeId>544bd20198ac84.54717789</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B41BBBE-B7A4-4FDE-B981-5D54B28AC9DE</gtr:id><gtr:title>Re-evaluation of SNP heritability in complex human traits</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/025466a6f52378a6cb32de7d945b59cf"><gtr:id>025466a6f52378a6cb32de7d945b59cf</gtr:id><gtr:otherNames>Speed D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58b4e2226fcff4.44710057</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09E5B128-B738-4681-813B-F7681101CD36</gtr:id><gtr:title>MultiBLUP: improved SNP-based prediction for complex traits.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/025466a6f52378a6cb32de7d945b59cf"><gtr:id>025466a6f52378a6cb32de7d945b59cf</gtr:id><gtr:otherNames>Speed D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>544bd20126a7c7.52306198</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43AC36D6-DF45-46E6-9EA5-0896DE50F85C</gtr:id><gtr:title>Genetic interactions with sex make a relatively small contribution to the heritability of complex traits in mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46614f9ad095b02e8844125fb5fdd40d"><gtr:id>46614f9ad095b02e8844125fb5fdd40d</gtr:id><gtr:otherNames>Krohn J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>544f7afbae2dd8.53498641</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF68312A-B39C-4CA3-B14B-EC26B53B8FA2</gtr:id><gtr:title>Integrating dynamic mixed-effect modelling and penalized regression to explore genetic association with pharmacokinetics.</gtr:title><gtr:parentPublicationTitle>Pharmacogenetics and genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/045cffd6f851e3023d782432b2084283"><gtr:id>045cffd6f851e3023d782432b2084283</gtr:id><gtr:otherNames>Bertrand J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1744-6872</gtr:issn><gtr:outcomeId>58b4e223837b50.63407439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>618A41AF-88EF-4978-AEC4-5022F17D13F7</gtr:id><gtr:title>Response to Lee et al.: SNP-based heritability analysis with dense data.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/025466a6f52378a6cb32de7d945b59cf"><gtr:id>025466a6f52378a6cb32de7d945b59cf</gtr:id><gtr:otherNames>Speed D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>544bd2016c1e85.01610918</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C1D8628-66F4-4484-8004-BF3361114417</gtr:id><gtr:title>Relatedness in the post-genomic era: is it still useful?</gtr:title><gtr:parentPublicationTitle>Nature reviews. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/025466a6f52378a6cb32de7d945b59cf"><gtr:id>025466a6f52378a6cb32de7d945b59cf</gtr:id><gtr:otherNames>Speed D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-0056</gtr:issn><gtr:outcomeId>doi_55faa1aa1f9d4eca</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FB28568-DAF5-4215-8BD6-092DC0E77E94</gtr:id><gtr:title>Describing the genetic architecture of epilepsy through heritability analysis.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/025466a6f52378a6cb32de7d945b59cf"><gtr:id>025466a6f52378a6cb32de7d945b59cf</gtr:id><gtr:otherNames>Speed D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>544bd200e7f7a2.86000879</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6D1519F-2127-4E27-911A-32FFCA55EAC2</gtr:id><gtr:title>Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c459b2c41c8bd00abd0dfd60fc6c0bb0"><gtr:id>c459b2c41c8bd00abd0dfd60fc6c0bb0</gtr:id><gtr:otherNames>International League Against Epilepsy Consortium on Complex Epilepsies. Electronic address: epilepsy-austin@unimelb.edu.au</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>544bd3aa72cc27.48778382</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC395888-C943-4C2B-B0CF-7B79AFD019E2</gtr:id><gtr:title>A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/025466a6f52378a6cb32de7d945b59cf"><gtr:id>025466a6f52378a6cb32de7d945b59cf</gtr:id><gtr:otherNames>Speed D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>doi_12417_hmg_ddt403</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BFAE93C-CB99-4331-AF28-B7A31FC052B6</gtr:id><gtr:title>The genomic and phenotypic diversity of Schizosaccharomyces pombe.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd4c9ea0b8d87b04bc45ef71ec2d8822"><gtr:id>bd4c9ea0b8d87b04bc45ef71ec2d8822</gtr:id><gtr:otherNames>Jeffares DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>doi_55faa1aa1f93b650</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0418BE3D-BF3B-44D4-998A-C9BFF887DF8C</gtr:id><gtr:title>Improved heritability estimation from genome-wide SNPs.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/025466a6f52378a6cb32de7d945b59cf"><gtr:id>025466a6f52378a6cb32de7d945b59cf</gtr:id><gtr:otherNames>Speed D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_12417_27_23217325</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0901388</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>12A0B409-0C29-4056-9092-2D86E44017F3</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.4  Methodologies and measurements</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>